Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0200
+0.0199 (19,900.00%)
Jun 15, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $2.53 million as of June 16, 2026. Its market cap has increased by 33.33% in one year.
Market Cap
2.53M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 2.53M, a decrease of -99.88%. That is a compound annual growth rate of -76.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 2.53M | 6,566.72% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 3.17M |
| Eastgate Biotech | 3.17M |
| Institute of Biomedical Research | 3.02M |
| LakeShore Biopharma | 2.88M |
| Vaccinex | 2.73M |
| Pacific Software | 2.69M |
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.14M |